Parkinson Disease Clinical Trials in San Francisco, California

6 studies are recruiting for parkinson disease in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Parkinson Progression Marker Initiative Online (PPMI Online)

   Parkinson Progression Marker Initiative Online (PPMI Online) is an observational study collecting participant reported information from people with and without Parkinson's disease (PD), for the goal of better understanding risk and predictive factors for PD. PPMI Online is part of the broader Parki…

   Stage

   Not phased

   Ages

   18 and older

   Site

   UCSF Movement Disorders and Neuromodulation Center (MDNC), San Francisco, California

   Run by

   Michael J. Fox Foundation for Parkinson's Research

   See if you can join NCT05065060 on ClinicalTrials.gov

2. Deep Brain Stimulation (DBS) Retrospective Outcomes Study

   The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.

   Stage

   Not phased

   Ages

   Any age

   Site

   University of California, San Francisco, San Francisco, California

   Locations

   20 in total

   Run by

   Boston Scientific Corporation

   See if you can join NCT03664609 on ClinicalTrials.gov

3. Psilocybin Therapy for Depression in Parkinson's Disease

   The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.

   Stage

   Phase 2

   Ages

   40 to 80

   Site

   University of California, San Francisco, San Francisco, California

   Run by

   Joshua Woolley, MD, PhD

   See if you can join NCT06455293 on ClinicalTrials.gov

4. PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

   The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest…

   Stage

   Not phased

   Ages

   30 and older

   Site

   University of California, San Francisco, San Francisco, California

   Locations

   50 in total

   Run by

   Michael J. Fox Foundation for Parkinson's Research

   See if you can join NCT04477785 on ClinicalTrials.gov

5. A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

   The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.

   Stage

   Phase 2

   Ages

   45 to 75

   Site

   University of California San Francisco (Neurology), San Francisco, California

   Locations

   46 in total

   Run by

   AskBio Inc

   See if you can join NCT06285643 on ClinicalTrials.gov

6. Understanding Motivation in Parkinson's Patients Through Neurophysiology

   The study aims to better understand motivation and value-based decision-making in Parkinson's patients through neurophysiology using Medtronic's Percept DBS device. By combining behavioral tasks with neural recordings, the study seeks to uncover how DBS affects motivation, particularly in relation …

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of California San Francisco, San Francisco, California

   Run by

   University of California, San Francisco

   See if you can join NCT05065151 on ClinicalTrials.gov